Our Mission
Microplate Dx’s mission is to vastly reduce deaths from drug-resistant infections by tackling the global threat to public health of antimicrobial resistance (AMR) and prolong the lifetime of our most treasured antibiotic stocks
Targeted Antimicrobial Prescribing The Microplate Dx platform enables rapid assessment of antibiotic susceptibility, enabling optimum antibiotic prescribing in under 1 hour. We are developing a multi-infection platform, with our first application in urinary tract infections (UTIs).
Newsroom
Microplate Dx wins runner-up in Converge Challenge 2021
Microplate Dx wins runner-up in Converge Challenge 2021
Microplate Dx wins runner-up in Converge Challenge 2021
Microplate Dx wins national pitching award
Microplate Dx wins runner-up in Converge Challenge 2021
Microplate Dx wins runner-up in Converge Challenge 2021
Contact Us
Find us at:
Microplate Dx Limited
WC514 Wolfson Centre
106 Rottenrow
Glasgow
G4 0NW
United Kingdom
